Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy

Clinical trial NCT05137899 · TERMINATED

Trial details

NCT number: NCT05137899
Sponsor: Ontario Clinical Oncology Group (OCOG)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Portal Vein Tumour Thrombosis

Start date: 2022-10-18
Primary completion: 2025-02-26
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.